Platelet-rich Plasma for Menical Tear

University of Malaga1 site in 1 country15 target enrollmentJanuary 2014

ConditionsPlatelet-Rich Plasma Meniscus Lesion

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Platelet-Rich Plasma
Sponsor: University of Malaga
Enrollment: 15
Locations: 1
Primary Endpoint: Visual Analog Scale
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Meniscal injuries are a common pathology among athletes, and have an impact on the daily or sporting practice of patients. Surgical approach implies sometimes heavy consequences. Platelet-rich-plasma (PRP) has been shown to be effective in accelerating wound healing and tissue regeneration in orthopedic and oral surgery. This clinical trial aims to investigate the safety and efficacy of intraarticular and periferal PRP injection in patients with stable meniscal injury. The pre- and post-interventional clinical outcomes will be compared.

Registry

clinicaltrials.gov

Start Date

January 2014

End Date

November 2019

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Malaga

Responsible Party

Principal Investigator

Ivan Medina-Porqueres

Professor

University of Malaga

Eligibility Criteria

Inclusion Criteria

•Skeletally mature patients 18-70 years of age
•With diagnosis of meniscus injury
•Single tear of the medial and/or lateral meniscus
•With no indication of meniscus repair surgery

Exclusion Criteria

•Prior history of multiple ligaments injury, associated significant ligament instability: Grade III MCL, Grade III PCL, or ACL deficient knee
•Prior history of knee surgery
•Discoid meniscus
•Osteoarthritic changes (Kellgren Lawrence scale \>2)
•Inflammatory diseases (i.e. rheumatoid arthritis)
•Underlying bleeding disorder or coagulopathy
•Concominant chondral defects (\> 2 ICRS)
•Cancer patients
•Pregnancy
•Patients who will not cooperate with six-month followup